Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis and HIV news

Show

From To
Restrictions on free DAA access in many European countries contrary to guidelines and undermine HCV elimination targets, say researchers

The restrictions which many European countries impose on free/reimbursed access to hepatitis C virus (HCV) direct-acting antivirals (DAAs) are contrary to guidelines and undermine the

Published
19 hours ago
By
Michael Carter
California declares state of emergency over deadly hepatitis A outbreak

California Gov. Brown declared a state of emergency Friday because of a hepatitis A outbreak that has killed at least 18 people in the state. The declaration allows state health officials to buy additional doses of the hepatitis A vaccine to try to halt the outbreak, which is already the nation’s second largest in more than two decades.

Published
16 October 2017
From
Los Angeles Times
Rapid fibrosis progression in large proportion of HIV-positive gay men after acute HCV

Over a third of HIV-positive gay men develop significant liver fibrosis after an episode of acute hepatitis C virus (HCV) infection, German investigators report in

Published
11 October 2017
By
Michael Carter
Egypt launches aggressive campaign to stamp out hepatitis C

Egypt has the highest rate of hepatitis C in the world. Now the country has undertaken an aggressive campaign to stamp out the disease, both domestically and abroad.

Published
06 October 2017
From
FRANCE 24
Hep C: An end in sight?

Despite its prevalence, hepatitis C has long been under-prioritised by health services. But could new drugs and a new commitment from the NHS mean we may finally see this killer condition eradicated?

Published
05 October 2017
From
Drink & Drug News
Hepatitis C Drug’s Lower Cost Paves Way For Medicaid, Prisons To Expand Treatment

Valerie Green is still waiting to be cured. The Delaware resident was diagnosed with hepatitis C more than two years ago, but she doesn’t qualify yet for the Medicaid program’s criteria for treatment with a new class of highly effective but pricey drugs. The recent approval of a less expensive drug that generally cures hepatitis C in just eight weeks may make it easier for more insurers and correctional facilities to expand treatment.

Published
05 October 2017
From
Kaiser Health News
People with HIV/HCV co-infection have an increased risk of cardiovascular disease compared to people with HIV alone

People with HIV/hepatitis C virus (HCV) co-infection are between a quarter and a third more likely to develop cardiovascular disease compared to people of a similar age

Published
05 October 2017
By
Michael Carter
The Hepatitis Drug Market Is Worse Than Wall Street Realises

Slowing hepatitis C drug sales have taken a bite out of Gilead's share price.This is a smart retreat for Merck and J&J. The HCV market is well past its peak. Both of their new therapies would have been very late; AbbVie and Gilead both had new drugs approved this year. Their best hope likely would have been to compete on price in a market that's been warring over price for a while.

Published
04 October 2017
From
Bloomberg
Drinking three or more cups of coffee a day halves the risk of dying for people with HIV/HCV co-infection

Drinking three or more cups of coffee a day halves the risk of death from any cause for people with HIV/hepatitis C virus (HCV) co-infection,

Published
03 October 2017
By
Michael Carter
Is HCV Drug Development Nearing Its End?

The FDA recently approved two new combination regimens for hepatitis C, raising the question of whether further drug development is warranted in this area. Experts agree, however, that more remains to be done in terms of implementation: getting everyone at risk screened for HCV infection, and getting those who test positive on effective treatment.

Published
02 October 2017
From
MedPage Today
← First12345...228Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.